GPR39 and prostate carcinoma: Activity of ZnR/GPR39 in tissues relevant to Zn2+ signaling has been identified in neurons, colon epithelial cells (colonocytes), skin epidermal cells (keratinocytes), pancreatic cells, prostate cancer cells, salivary gland cells, and in bones [57,58,59,60,61].